Originally published May 1, 2014. Restored and updated November 18, 2026. This article covers a historical recall and includes updated official safety information.
LiteFit USA was recalled in 2014 after FDA testing found undeclared sibutramine in the weight-loss supplement. This is a record of that event, not an announcement of a new recall.
Which product was recalled?
Bacai’s April 29, 2014 announcement, preserved in an Indiana health department recall notice, identified:
- Product: LiteFit USA, also written as Lite Fit USA.
- Packaging: Bottles containing 30 softgels.
- Lot: 13165.
- Expiration: May 2017.
- Distributor: Bacai, Inc.; the notice described worldwide wholesale, retail and internet distribution.
The notice covered Bacai’s distribution from June 26, 2013 through March 27, 2014. These identifiers describe the historical product; a similar name alone does not establish that another product is the same one.
Why did the FDA warn consumers?
The FDA’s April 10, 2014 notification advised against buying or using Lite Fit USA. Sibutramine had been removed from the market in October 2010 for safety reasons. FDA warned of increased blood pressure or pulse, cardiovascular risks and potentially serious interactions with other medicines.
Where to get help now
Do not use leftover stock of the recalled product. If you have a concern after taking it, contact a healthcare professional and keep the packaging or a photograph of its label for identification. Product problems can be reported through FDA MedWatch.
The old notice’s return arrangements are historical; current refund availability has not been verified.

Leave a Reply